![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Abstract
An exploratory pilot group of ten women receiving highly emetic cancer chemotherapy received an experimental clinical relaxation program designed to diminish nausea and vomiting. Results indicated that duration of emetic response, frequency of vomiting, intensity of episodic effort and volume of emesis were reduced substantially when compared to the known clinical course for patients receiving these agents. Further, a pattern of emetic response characterized by three phases was identified and is anticipated to provide criteria allowing for more precise patient assessment and improved antiemetic regimen evaluation. In addition, data gathered provided a base for development of an emetic response rating scale.